Strontium.
May support bone health and density. It's a mineral that gets incorporated into bone. The idea is it encourages bone-building cells and slows down the cells that break bone down.
Reviewed March 2026
- Category
- Mineral
- Also filed under
- Bone health supportPotential increase in bone mineral density
What Strontium is, and what it does.
- Does it work
- Maybe. It's not a slam dunk. If bone density is a concern and you've maxed out Vitamin D, K2, and Calcium, this could be a next step. But don't start here.
- How much to take
- 340-680mg of elemental strontium daily. Take it away from food, and especially calcium supplements, by at least 2 hours.
- Time to feel it
- This works on a months to years timescale. The change is read on a bone density scan rather than noticed, and even then the reading needs correcting first.
- The first dose
- Absolutely nothing. This is a long-game supplement. It needs months to show any effect.
- With regular use
- The goal is seeing an improvement on your next bone density (DEXA) scan. This can take a year or more. It's not about how you feel.
- How well tolerated
- Generally well tolerated at supplement amounts. Take it away from calcium, and speak with a clinician first if you have kidney or heart history, or are pregnant or breastfeeding.
- How it feels
- Like taking nothing. It works in the background on a structural level. Don't expect to feel calmer, stronger, or anything else.
- The overlooked benefit
- Because strontium blocks X-rays more strongly than calcium does, it inflates a bone density reading. Ask for the corrected figure, or the scan will overstate the change.
340 to 680mg a day is where Strontium works.
Source: Meunier et al., NEJM, 2004 (strontium ranelate); supplements use strontium citrate
The proof, claim by claim.
These words describe the research, not the molecule's worth. Research strength is how much work stands behind one claim, and it is never a product score.
While strontium ranelate was a pharmaceutical drug for osteoporosis, its use has been restricted due to cardiovascular risks. Supplement forms like strontium citrate are considered safer but have less robust evidence. More research is needed to fully understand the benefits and risks of different strontium forms.
- bone mineral densityRandomised trial
- incorporation into bone mineralNarrative review
- competition with calcium for intestinal absorptionNarrative review
- calcium sensing receptor signalling in bone cellsIn vitro study
Questions people ask about Strontium.
- Is this the radioactive stuff from Chernobyl?
- No. That's Strontium-90, a radioactive isotope. This is a stable, natural mineral found in soil and water. Completely different.
- Can I take this with my calcium supplement?
- No. Take them at least 2 hours apart. They use the same doorways to get into your system and will block each other.
- Does it actually build new bone?
- It seems to nudge the balance toward bone-building. But be aware it can also make bone density scans look artificially high because strontium is heavier than calcium.
- Who is this supplement actually for?
- Mainly postmenopausal women with bone density concerns who are already covering their bases with calcium, vitamin D, and K2.
- Will it make my bones stronger?
- That's the goal. It aims to increase density, which should translate to strength. The data on actual fracture reduction for the supplement forms is still developing.
Why these belong in the same formula. Each row says what the basis is, from settled biochemistry through to a trial that measured the pair.
Strontium and calcium are chemically similar divalent cations and compete for the same intestinal transport and binding proteins, so taken in the same serving each lowers uptake of the other. Standard practice is to separate them by several hours rather than combine them.
Vitamin D3 raises expression of the intestinal calcium transporters and binding proteins that strontium also travels on, so vitamin D status affects how much strontium crosses the gut wall. It also keeps normal calcium handling intact while a second cation is present.
Vitamin K2 is the cofactor that carboxylates osteocalcin and matrix Gla protein, the proteins that bind mineral into bone tissue. Strontium is taken up into that same hydroxyapatite lattice, so the two act on different steps of one normal bone-turnover process.
Vitamin C is the required cofactor for the prolyl and lysyl hydroxylases that build and crosslink bone collagen, so it supports the matrix that bone mineral is laid onto.
Strontium and calcium are taken up by the same intestinal calcium transport machinery and each reduces uptake of the other, which is why the two are dosed at separate times rather than in one tablet.
Strontium competes with calcium for the same absorption route, and the large mass of a carbonate calcium dose crowds it out. Standard practice separates the two doses.
MK-7 carboxylates osteocalcin so it can bind mineral into the bone matrix and keeps matrix Gla protein active in soft tissue, the step that directs supplemental bone mineral to bone.
Silicon supports the collagen scaffold that bone mineral is deposited onto, so it works on the organic side of bone while strontium acts on the mineral side.
Boron shifts how the body retains calcium and magnesium and supports the vitamin D and steroid hormone steps involved in normal bone turnover, which is why it sits in bone formulas.
Manganese is the metal cofactor for the glycosyltransferases that assemble bone and cartilage proteoglycan, a step in matrix building that the mineral phase does not cover.
Collagen peptides supply the glycine and proline building blocks and peptide signals for the type I collagen framework of bone, the scaffold onto which mineral is deposited.
Bulk soluble fibre binds divalent minerals in the gut lumen and carries a fraction of them past the absorption window, so strontium taken with a psyllium dose is less available.
Magnesium and strontium are both divalent cations absorbed partly through saturable transcellular routes and partly by paracellular diffusion, so a large bolus of one reduces fractional absorption of the other taken at the same time. Magnesium is also a structural component of the hydroxyapatite surface layer. The interaction is about timing rather than incompatibility, and separating the doses is the usual answer.
Zinc absorption falls when large amounts of other divalent cations are taken in the same dose, a well characterised effect for calcium and one that applies to the chemically similar strontium ion. Neither mineral is destroyed, the absorbed fraction simply drops. Spacing them by a couple of hours removes most of the effect.
Non-heme iron absorption is reduced by large concurrent doses of calcium, and strontium behaves like calcium at the intestinal interface. Anyone taking both should separate them across the day. This is settled absorption pharmacology and needs no combination trial.
Hydroxyapatite is a calcium phosphate lattice, and strontium enters that lattice by substituting for calcium at surface sites. Phosphate is the counter-ion that makes the mineral phase possible in the first place. Very high phosphate intake also forms poorly soluble complexes in the gut lumen that reduce divalent cation absorption, so the relationship runs both ways.
Caffeine produces a modest increase in urinary calcium excretion, and strontium is handled by the kidney along the same tubular routes as calcium. The size of the effect is small at habitual intakes and is offset by adequate mineral intake. Read it as a handling effect on a marker, not as a bone outcome.
High sodium intake raises urinary calcium loss because sodium and calcium share reabsorption pathways in the proximal tubule and loop of Henle. Strontium follows calcium's renal handling closely enough that the same relationship applies. It is a urinary marker effect with an established mechanism.
Fermentation of inulin in the colon produces short chain fatty acids that lower luminal pH, keeping divalent cations soluble and increasing paracellular absorption in the large intestine. The effect is documented for calcium and magnesium and applies to chemically similar cations. Whether it changes any strontium endpoint has not been measured.
Short chain fructans are fermented rapidly in the proximal colon, dropping pH and holding divalent cations in solution where they can be absorbed. The mechanism is the same one described for inulin. It is an absorption mechanism rather than a demonstrated bone effect.
Galactooligosaccharides are fermented to short chain fatty acids and have been studied for their effect on calcium absorption in adolescents. Strontium shares calcium's absorption chemistry closely. The extrapolation is mechanistic and should be labelled as such.
Phytic acid in whole grains and legumes binds divalent cations into insoluble complexes that pass through unabsorbed, and phytase hydrolyses the phosphate groups that do the binding. Removing phytate raises the absorbable fraction of calcium, zinc, iron and chemically similar cations including strontium. The chelation chemistry is textbook.
Activated charcoal adsorbs a wide range of substances in the gut lumen without discriminating between them, which includes mineral ions taken at the same time. Any mineral dose should be separated from charcoal by several hours. This is general adsorbent pharmacology.
Bentonite is a layered aluminosilicate with a high cation exchange capacity, so it binds divalent cations from the gut lumen. Taken together with a mineral, it reduces the fraction available for absorption. Separation in time is the practical answer.
Carbonate mineral salts need gastric acid to dissolve into absorbable ions, while citrate and gluconate salts are already largely dissociated and are less dependent on stomach acid. In people with reduced gastric acidity this difference matters for the carbonate form specifically. Acidifying agents are used in formulation for that reason.
Vitamin K is the cofactor for gamma-carboxylation of osteocalcin and matrix Gla protein, which is what lets those proteins bind calcium in the bone matrix. Strontium acts on the mineral phase; vitamin K acts on the protein scaffold that mineral deposits against. The two address different halves of the same tissue.
Lysyl oxidase is a copper-dependent enzyme that forms the covalent cross-links holding collagen fibrils together, and that collagen network is the template on which bone mineral is laid down. Copper supports the organic matrix while strontium interacts with the mineral phase. High doses of other divalent minerals can also reduce copper absorption, so both directions matter.
Calcitriol upregulates TRPV6 and calbindin in the enterocyte, the transcellular machinery that carries calcium across the brush border, and strontium uses that same machinery. Adequate vitamin D status therefore raises the absorbed fraction. This is established transport biology.
Talk to a doctor before taking Strontium if any of these apply to you: Kidney issues, Cardiovascular concerns (with certain forms and higher doses). These are flags to check first, not effects Strontium is known to cause.
Not medical advice. Show the label to your pharmacist.What Strontium actually does.
Strontium sits directly under calcium on the periodic table and behaves like a bigger version of it. In bone it swaps in at the surface of the mineral crystal rather than replacing calcium all the way through.
Strontium rides the same two gut routes as calcium, an active carrier system at low intakes and passive leak between cells at higher ones. That shared path is why the two get in each other's way when taken together.
Your kidneys handle strontium much like calcium but reclaim less of it, so more shows up in urine and blood levels drop off faster than calcium once you stop taking it.
Strontium is heavier than calcium, so it blocks X-rays harder. Bone that has taken it up reads denser on a DXA scan than it really is. That's a quirk of the measurement, not a change in the bone itself.
Where Strontium comes from.
It comes out of the ground as an ore, gets cleaned up through a dissolve and recrystallise cycle, and is then joined to citric acid or a similar acid to make a powder that dissolves properly. Because it is mined, the testing that matters is for the metals that travel with it in the rock, which is why a certificate of analysis for lead and barium is part of the picture.
From a mineral source, then refined and usually bound to a carrier so the body can take it up.
Commercial strontium starts from celestine, which is strontium sulfate, or less commonly from strontianite, which is strontium carbonate. Celestine dominates because of its wider deposits.
Celestine is either reduced with carbon at high temperature to strontium sulfide and then carbonated, or converted directly with sodium carbonate solution to strontium carbonate. Both routes end at the carbonate as the trade intermediate.
Crude carbonate is dissolved in acid, filtered to remove insoluble residues, and the strontium salt is recrystallised. Barium is the impurity of most concern because it accompanies strontium geologically and has to be controlled by specification.
Purified strontium is reacted with citric, lactic or gluconic acid to make the corresponding organic salt, or held as the carbonate. The anion choice sets solubility, elemental yield per gram and pH dependence.
Batches are assayed for elemental strontium by ICP and tested against limits for lead, arsenic, cadmium and barium, which is the release control that matters for a mineral of geological origin.
Getting Strontium from food.
The whole-food sources on file. A supplement closes the gap, it does not replace dinner.
A gram-for-gram figure (how much of each you would eat to match a dose) will appear here once it is sourced and reviewed. This page will not print a number it cannot cite.
The forms it comes in.
The essence, in one line each.
- In a network meta-analysis of 125 randomised trials covering 12,541 people, strontium toothpaste reduced tooth sensitivity to a touch stimulus more than fluoride toothpaste, with a standardised mean difference of 1.43 and moderate certainty.Meta-analysis. Martins et al., 2020 (Journal of Dental Research). PMID 32037944 ↗
- Pooling nine trials, strontium acetate toothpaste lowered tooth sensitivity scores more than placebo at every time point and stimulus tested, while strontium chloride performed the same as placebo.Meta-analysis. Grünberg et al., 2017 (American Journal of Dentistry). PMID 29178705 ↗
- Over one year in women after midlife with lower than normal bone density, a nightly combination of melatonin, strontium citrate, vitamin D3 and vitamin K2 raised lumbar spine bone mineral density by 4.3% and left femoral neck by 2.2% compared with placebo, so the effect belongs to the blend rather than to strontium alone.Randomised trial. Maria et al., 2017 (Aging). PMID 28130552 ↗
- Across 30 randomised trials, no difference was detected between strontium, potassium and calcium sodium phosphosilicate toothpastes for tooth sensitivity at 2, 4 and 8 weeks, and the placebo response itself was large.Meta-analysis. Hu et al., 2019 (Journal of Dentistry). PMID 31325467 ↗
- The authors pooled preclinical studies of strontium supplementation around dental implants and reported greater bone to implant contact under conditions of reduced bone density; the included work is animal and in vitro rather than human clinical.Systematic review. Lu et al., 2022 (The Journal of Prosthetic Dentistry). PMID 33589234 ↗
- The review describes how strontium incorporated into biomaterials influences osteoblast and osteoclast activity, and notes that most of the supporting data comes from laboratory and animal models rather than clinical endpoints.Narrative review. Ning et al., 2026 (International Journal of Nanomedicine). PMID 42338898 ↗
- Strontium-containing bioactive glass nanoparticles increased osteogenic markers and reduced osteoclast formation in a co-culture system.In vitro study. Naruphontjirakul et al., 2026 (Advanced Healthcare Materials). PMID 41137437 ↗
- A strontium chelate carried on a plant polysaccharide was associated with greater bone regeneration in the animal defect model used.Animal study. Ding et al., 2026 (Phytomedicine). PMID 41861682 ↗
- Strontium supplementation altered gut microbiota composition and retinoic acid metabolism alongside improvements in cartilage and bone measures in the birds studied.Animal study. Huang et al., 2026 (NPJ Biofilms and Microbiomes). PMID 42265117 ↗
- Human mesenchymal stem cells cultured on bioactive glass-coated implant surfaces, a class of material that commonly carries strontium, showed differentiation toward an osteogenic phenotype.In vitro study. Dutta et al., 2026 (Bioinformation). PMID 42282328 ↗
These are the studies our verdict leans on, chosen from the 104 we read for Strontium. The full linked list is below.
The studies, linked.
12 sources behind our Strontium verdict: peer-reviewed studies and registered clinical trials. Every one links straight to PubMed, the journal, or ClinicalTrials.gov. Read them yourself.
- Clinical trialA Dose-response Study With Strontium Malonate in Postmenopausal Women. A 12 Week, Multi National, Double Blind, Randomized, 5 Arms, Parallel Group Placebo Controlled Open Label Active Controlled, Phase II Study With 3 Dose Levels of Strontium Malonate and Protelos Within Post Menopausal Women With a BMDT-score Below -1ClinicalTrials.gov ↗PHASE2 · 275 participants · Completed
- Clinical trialA Prospective Randomized Phase III, Trial Comparing Consolidation Therapy With or Without Strontium-89 Following Induction Chemotherapy in Androgen-Independent Prostate CancerClinicalTrials.gov ↗PHASE3 · 265 participants · Terminated
- Clinical trialA PROSPECTIVE MULTICENTER RANDOMIZED STUDY COMPARING STRONTIUM-89 CHLORIDE AND PALLIATIVE LOCAL FIELD RADIOTHERAPY IN PATIENTS WITH HORMONAL ESCAPED ADVANCED PROSTATIC CANCERClinicalTrials.gov ↗PHASE3 · 204 participants · Completed
- Clinical trialA Prospective Study to Estimate Inadvertent Radiation Exposure From Strontium Isotopes in Patients Who Have Undergone CardioGen-82® PET MPI ScanningClinicalTrials.gov ↗155 participants · Completed
- Clinical trialImmediate And Sustained Treatment Response Of Commercially Available BioMin F, Colgate Sensitive Pro-Relief And Sensodyne Rapid Action Dentifrices In Dentin Hypersensitivity - "A Randomized Clinical Trial"ClinicalTrials.gov ↗PHASE3 · 140 participants · Completed
- Clinical trialEFFECTIVENESS OF A HOMECARE DESENSITIZER FOR PATIENTS WITH DENTIN HYPERSENSITIVITYClinicalTrials.gov ↗PHASE2 · 126 participants · Completed
- Clinical trialSuccessful Pregnancy and Delivery After AOA in Couples With Repeated Complete Fertilization Failure or Low Fertilization RatesClinicalTrials.gov ↗NA · 100 participants · Completed
- Clinical trialA Randomized, Double-blind Clinical Trial to Assess the Instant and Lasting Relief Effects of a Dentifrice Containing 2% Strontium Chloride and 5% Potassium Nitrate on Dentin HypersensitivityClinicalTrials.gov ↗NA · 79 participants · Completed
- Clinical trialDifferential Effects of Teriparatide and Strontium Ranelate on Bone Remodeling and Formation in Postmenopausal Women With OsteoporosisClinicalTrials.gov ↗PHASE4 · 73 participants · Completed
- Clinical trialPrimary Hyperparathyroidism: Does a Systematic Treatment Improve the Calcium- and Bone Metabolism After Successful Surgery? - Part IClinicalTrials.gov ↗PHASE4 · 63 participants · Completed
- Clinical trialA Randomized Phase II Trial of Strontium-89 With or Without Cisplatin for the Palliation of Bone Pain Secondary to Hormone Refractory Prostate CancerClinicalTrials.gov ↗PHASE2 · 58 participants · Completed
- Clinical trialPercutaneous Injection of Strontium Containing Hydroxyapatite Versus Polymethacrylate Plus Short Segment Pedicle Screw Fixation for Traumatic A2 and A3 AO-type Fractures in AdultsClinicalTrials.gov ↗38 participants · Completed
Evidence surfaced via Semantic Scholar (Allen Institute for AI) and ClinicalTrials.gov. Ranked by study type and citation weight, not cherry-picked.
Problems people have reported.
Read this carefully. These are 5,385 voluntary, unverified reactions reported to the FDA (openFDA). The number mostly reflects how popular Strontium is, not how risky it is. A report is not proof Strontium caused anything. It is a signal of what to watch for, nothing more.
Source: openFDA adverse-event reports. Voluntary reporting, not an incidence rate.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.
